Neurovascular damage in experimental allergic encephalomyelitis: a target for pharmacological control
The blood-brain barrier (BBB) is composed of a continuous endothelial layer with pericytes and astrocytes in close proximity to offer homeostatic control to the neurovasculature. The human demyelinating disease multiple sclerosis and the animal counterpart experimental allergic encephalomyelitis (EA...
Saved in:
| Main Author: | C. Bolton |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
1997-01-01
|
| Series: | Mediators of Inflammation |
| Online Access: | http://dx.doi.org/10.1080/09629359791415 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Experimental allergic encephalomyelitis: peculiarities of pain-relieving therapy and place of anticonvulsants as analgetics
by: Nefyodov O.O., et al.
Published: (2015-11-01) -
CXCL13 Damages Blood Spinal Cord Barrier by Promoting RNF6/Sqstm1‐Ubiquitination Induced Autophagy in Experimental Allergic Encephalomyelitis
by: Jingjing Han, et al.
Published: (2025-06-01) -
Experimental allergic encephalomyelitis: peculiarities of pain-relieving therapy and place of anti¬con¬vulsants as analgetics.
by: O. O. Nefyodov, et al.
Published: (2015-11-01) -
Environmentdependent microcirculatory and autonomic neurovascular changes in the children with allergic rhinitis
by: P. V. Berezhanskiy, et al.
Published: (2022-04-01) -
GDNF Enhances Therapeutic Efficiency of Neural Stem Cells-Based Therapy in Chronic Experimental Allergic Encephalomyelitis in Rat
by: Xiaoqing Gao, et al.
Published: (2016-01-01)